Know What's Happening in Technology

From DNA To Decision

Rapid functional testing is turning ambiguous genetic variants into actionable medical decisions. A zebrafish model proved a newborn‑identified SMN1 mutation benign, allowing clinicians to defer costly SMA therapy. This proof‑of‑concept shows whole‑genome sequencing can move from data to diagnosis within days. The approach promises to scale across rare‑disease screening programs worldwide.